Registration for PeproTech.com is no longer available. To order your PeproTech products online, register or logon to ThermoFisher.com.

Biotinylated Polyclonal Antibodies

Biotinylated Anti-Human IP-10 (CXCL10)

0 ReviewsSubmit a Review

Product Details

Catalog Number: 500-P93BT
Description:
Biotinylated Anti-Human IP-10 (CXCL10)
 

Source: Polyclonal Rabbit

Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant hIP-10. Anti-Human IP-10 specific antibody was purified by affinity chromatography and then biotinylated.

Immunogen: E.coli derived Recombinant Human IP-10 (CXCL10) (PeproTech catalog# 300-12)

Sandwich ELISA: To detect hIP-10 by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.25 – 1.0 μg/ml of this antibody is required. This biotinylated polyclonal antibody, in conjunction with PeproTech’s Polyclonal Anti-Human IP-10 (500-P93) as a capture antibody, allows the detection of at least 0.2 – 0.4 ng/well of recombinant hIP-10.

Biotinylated Anti-Human IP-10 (CXCL10) Sandwich ELISA

Western Blot: To detect hIP-10 by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hIP-10 is 1.5 - 3.0 ng/lane, under either reducing or non-reducing conditions.

Biotinylated Anti-Human IP-10 (CXCL10) Western Blot Reduced Biotinylated Anti-Human IP-10 (CXCL10) Western Blot Unreduced

Note:

1mg will be provided as 2x500μg.

Cross Reactivity Cited in References:
Country Of Origin: USA

Not for human use.

Research Interest

Recent Citations

First Author
Bouhaddou, M
Title
The Global Phosphorylation Landscape of SARS-CoV-2 Infection.
Citation
Cell; 182(3) pg685-712.e19
PubMed ID
First Author
Loos, T
Title
Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Citation
Blood; 112(7) pg2648-56
PubMed ID
First Author
Pilette, C
Title
CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge.
Citation
The European Respiratory Journal; 23(6) pg876-84
PubMed ID